Targeted Organ (Neurology, Cardiovascular)

Aims & Scope

The Targeted Organ Neurology Subcommittee:

  • Promote cutting-edge pre-clinical science supporting clinical investigations of cell therapies in neurological diseases/critical illnesses.
  • Promote the development and implementation of cell-based therapies for neurological diseases/critical illnesses in a careful and considered manner. 
  • Provide a forum for communication and data/database sharing between investigators involved in clinical investigations of cell therapies for neurological diseases/critical illnesses.

The Targeted Organ Cardiovascular Subcommittee:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the solid organ targeted therapy pre-clinical/clinical studies category.
  • Review the status of the cardiovascular field and compile a list of major scientific issues that must be addressed to advance or enable cellular therapies.
  • Publish position papers and engage scientific discourse as necessary to advance the field.

Neurology Subcommittee

Headshot of Charles S. Cox Jr.


Charles S. Cox Jr., MD
January 2018 - Present

Children’s Program in Regenerative Medicine
Houston, United States

Headshot of Robert Mays


Robert (Willie) Mays, MD
January 2018 - Present

Athersys, Inc.
Cleveland, United States


Ingrid Catz, MSc
Vancouver, Canada

Cardiovascular Subcommittee

Headshot of Massimiliano Gnecchi


Massimiliano Gnecchi, MD, PhD
June 2016 - Present

University of Pavia IRCCS Policlinico San Matteo
Pavia, Italy


Hendrick Jan Ankersmit, MD, PD, MBA
Medical University of Vienna
Vienna, Austria

Sveva Bollini, PhD
University of Genova
Genova, Italy